Francis M Cuss - Net Worth and Insider Trading
Francis M Cuss Net Worth
The estimated net worth of Francis M Cuss is at least $13 Million dollars as of 2024-09-20. Francis M Cuss is the EVP & CSO of Bristol-Myers Squibb Co and owns about 266,033 shares of Bristol-Myers Squibb Co (BMY) stock worth over $13 Million. Francis M Cuss is also the Director of Rubius Therapeutics Inc and owns about 10,000 shares of Rubius Therapeutics Inc (RUBY) stock worth over $570. Details can be seen in Francis M Cuss's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Francis M Cuss has not made any transactions after 2018-07-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Francis M Cuss
Francis M Cuss Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Francis M Cuss owns 2 companies in total, including Rubius Therapeutics Inc (RUBY) , and Bristol-Myers Squibb Co (BMY) .
Click here to see the complete history of Francis M Cuss’s form 4 insider trades.
Insider Ownership Summary of Francis M Cuss
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RUBY | Rubius Therapeutics Inc | 2018-07-20 | director |
BMY | Bristol-Myers Squibb Co | 2015-03-16 | EVP & CSO |
Francis M Cuss Latest Holdings Summary
Francis M Cuss currently owns a total of 2 stocks. Among these stocks, Francis M Cuss owns 266,033 shares of Bristol-Myers Squibb Co (BMY) as of March 16, 2015, with a value of $13 Million and a weighting of 100%. Francis M Cuss also owns 10,000 shares of Rubius Therapeutics Inc (RUBY) as of July 20, 2018, with a value of $570 and a weighting of 0%.
Latest Holdings of Francis M Cuss
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BMY | Bristol-Myers Squibb Co | 2015-03-16 | 266,033 | 49.41 | 13,144,691 |
RUBY | Rubius Therapeutics Inc | 2018-07-20 | 10,000 | 0.06 | 570 |
Holding Weightings of Francis M Cuss
Francis M Cuss Form 4 Trading Tracker
According to the SEC Form 4 filings, Francis M Cuss has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 114,666 shares on March 16, 2015, which brought Francis M Cuss around $8 Million.
According to the SEC Form 4 filings, Francis M Cuss has made a total of 0 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years. The most-recent trade in Rubius Therapeutics Inc is the acquisition of 10,000 shares on July 20, 2018, which cost Francis M Cuss around $230,000.
Insider Trading History of Francis M Cuss
- 1
Francis M Cuss Trading Performance
GuruFocus tracks the stock performance after each of Francis M Cuss's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Francis M Cuss is -35.46%. GuruFocus also compares Francis M Cuss's trading performance to market benchmark return within the same time period. The performance of stocks bought by Francis M Cuss within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Francis M Cuss's insider trading performs compared to the benchmark.
Performance of Francis M Cuss
Francis M Cuss Ownership Network
Francis M Cuss Owned Company Details
What does Rubius Therapeutics Inc do?
Who are the key executives at Rubius Therapeutics Inc?
Francis M Cuss is the director of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .
Rubius Therapeutics Inc (RUBY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rubius Therapeutics Inc Insider Transactions
Francis M Cuss Mailing Address
Above is the net worth, insider trading, and ownership report for Francis M Cuss. You might contact Francis M Cuss via mailing address: Bristol-myers Squibb Company, Route 206 & Province Line Road, Princeton Nj 08543.